Charlie is a senior counsel in our Cambridge office specialising in the commercialisation of intellectual property in the life sciences and technology sectors.
Charlie specialises in the commercialisation of intellectual property in the life sciences and technology sectors. He works with clients on key strategic transactions throughout their lifecycle. This ranges from advising start-ups on foundational licensing deals and R&D collaborations through to working with established multinational companies on distribution, manufacturing and other commercial arrangements. He also advises on the IP, commercial and regulatory aspects of VC investment and M&A.
With over a decade of experience in the Cambridge ecosystem, Charlie has a particular focus on leveraging his later-stage experience when advising early-stage clients and regularly delivers training to new founders taking part in life sciences incubators and accelerators throughout the UK.
Leading associate
Intellectual Property
Corporate and commercial - Cambridge
by Colin McCall and Charlie Adams
Advising on Draig Therapeutics' US$140 million series A financing
by multiple authors
Antiverse and Nxera Pharma enter collaboration to design novel GPCR-targeted antibody therapeutics
by Colin McCall and Charlie Adams
by Kathleen Munstermann-Senff, LL.M. (Medizinrecht) and Dr. Daniel Tietjen
by Jason Rawkins and Simon Jupp
by Dr. Christian Frank, Licencié en droit (Paris II / Panthéon-Assas)
by multiple authors
by multiple authors
by Giles Crown
by Charlotte Peach and Giles Crown